课题基金 / 基金详情

Linking redox chemistry and mitochondria in atrium to post-operative arrhythmia

Linking redox chemistry and mitochondria in atrium to post-operative arrhythmia
将心房中的氧化还原化学和线粒体与术后心律失常联系起来
批准号:
8092793
负责人:
Ethan John Anderson
金额:
$17.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-06-17 至 2013-05-31

项目摘要

项目成果

Ethan John Anderson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Post-operative atrial fibrillation (POAF) in patients following cardiac revascularization surgery is a significant health care burden and estimates of occurrence range from 15-65%. The mechanisms by which this occurs remain unknown, and a bio-marker for identifying those patients that are more vulnerable, or pre-disposed, to POAF would be highly valuable to clinicians. The studies proposed in this grant proposal will have a target cohort of 300 adult patients undergoing elective cardiac revascularization surgery via cardiopulmonary bypass. Samples of right atrial appendage will be obtained from these patients during surgery, and the following Specific Aims have been constructed to test the CENTRAL HYPOTHESIS that a diminished glutathione antioxidant capacity in myocardial tissue at the time of surgery pre-disposes a patient to developing POAF, and that this diminished antioxidant capacity is linked to increased mitochondrial oxidant emission. Aim 1): To determine if decreased glutathione content or glutathione-related enzyme activity in a patient's atrium at the time of surgery is linked to the development of POAF. The concentration of intracellular reduced (GSH) and oxidized (GSSG) glutathione will be assessed in samples of right atrial appendage obtained from patients directly prior to institution of cardiopulmonary bypass as outlined above. The specific activities of glutathione peroxidase (H2O2 scavenging) and glutathione reductase (regenerates GSH from GSSG) will also be assessed in each sample. Patients will then be continuously monitored with ECG post-operatively until discharge from hospital, and the glutathione data for each patient will then be compared with the post-operative ECG profile of that patient to determine whether there is a link between glutathione content and/or glutathione-related enzyme activity in a patient's atrium at the time of surgery and the development of POAF. Aim 2): To determine whether elevated rates of mitochondrial oxidant emission are linked to diminished glutathione antioxidant capacity in myocardial tissue of patients undergoing CABG surgery. Mitochondrial H2O2 emission supported by endogenous substrate oxidation at baseline and following exogenous Ca2+ uptake will be assessed in permeabilized atrial myofibers prepared from samples of right atrial appendage obtained from patients directly prior to institution of cardiopulmonary bypass. These data will then be analyzed together with the glutathione data, to establish whether high rates of mitochondrial H2O2 emission are associated with reduced glutathione content and/or enzyme activity in atrial tissue. CLINICAL SIGNIFICANCE: It is anticipated that the findings from this project will result in identification of biochemical markers that may be able to identify patients at higher risk for developing POAF, in addition to providing a first step towards elucidating a potential mechanism by which POAF occurs. PUBLIC HEALTH RELEVANCE: Atrial fibrillation (irregular heartbeat) is one of the most common complications after open heart surgery. Its incidence ranges from 20% to 40% in most published series. Significant adverse effects include stroke, increased risk of death, and increased length of stay in hospital, resulting in a large financial burden to hospitals and clinics. Little is known about the mechanism for the development of this arrhythmia, and more importantly why it occurs in some patients and not in others. The studies proposed here are directed towards identifying a biochemical marker which could identify patients who are at increased risk of developing postoperative atrial fibrillation, and towards further understanding of the causative factors underlying its development.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3410/m4-13
发表时间: 2012-01-01
期刊: F1000 medicine reports
影响因子: --
作者: [Anderson, Ethan J, Taylor, David A]
通讯作者: Taylor, David A
DOI: 10.1161/jaha.113.000713
发表时间: 2014-02-26
期刊: Journal of the American Heart Association
影响因子: 5.4
作者: [Anderson EJ, Efird JT, Davies SW, O'Neal WT, Darden TM, Thayne KA, Katunga LA, Kindell LC, Ferguson TB, Anderson CA, Chitwood WR, Koutlas TC, Williams JM, Rodriguez E, Kypson AP]
通讯作者: Kypson AP
DOI: 10.1042/bj20110626
发表时间: 2012-01-01
期刊: The Biochemical journal
影响因子: --
作者: [Anderson EJ, Thayne K, Harris M, Carraway K, Shaikh SR]
通讯作者: Shaikh SR
DOI: 10.1089/ars.2014.5888
发表时间: 2014-09-10
期刊: ANTIOXIDANTS & REDOX SIGNALING
影响因子: 6.6
作者: [Anderson, Ethan J., Thayne, Kathleen A., Rodriguez, Evelio]
通讯作者: Rodriguez, Evelio
Determinants of cardioprotection by circulating prohibitin-1 during sepsis
  • 批准号:
    10577340
  • 项目类别:
  • 资助金额:
    $45.41万
  • 财政年份:
    2023
  • 负责人:
    Ethan John Anderson
  • 依托单位:
Myocardial redox status, catecholamine metabolism and post-operative arrhythmia
  • 批准号:
    9295043
  • 项目类别:
  • 资助金额:
    $40.8万
  • 财政年份:
    2016
  • 负责人:
    Ethan John Anderson
  • 依托单位:
Myocardial redox status, catecholamine metabolism and post-operative arrhythmia
  • 批准号:
    9102173
  • 项目类别:
  • 资助金额:
    $4.27万
  • 财政年份:
    2014
  • 负责人:
    Ethan John Anderson
  • 依托单位:
Myocardial redox status, catecholamine metabolism and post-operative arrhythmia
  • 批准号:
    8674060
  • 项目类别:
  • 资助金额:
    $48.36万
  • 财政年份:
    2014
  • 负责人:
    Ethan John Anderson
  • 依托单位:
海外基金